BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16033259)

  • 1. Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis.
    Meiering S; Inhoff O; Mies J; Vincek A; Garcia G; Kramer B; Dormeyer M; Krauth-Siegel RL
    J Med Chem; 2005 Jul; 48(15):4793-802. PubMed ID: 16033259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking of a series of peptidomimetics in the trypanothione binding site of T. cruzi trypanothione reductase.
    da Rocha Pita SS; Cirino JJ; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
    J Mol Graph Model; 2009 Nov; 28(4):330-5. PubMed ID: 19766515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.
    Parveen S; Khan MO; Austin SE; Croft SL; Yardley V; Rock P; Douglas KT
    J Med Chem; 2005 Dec; 48(25):8087-97. PubMed ID: 16335933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.
    Chan C; Yin H; McKie JH; Fairlamb AH; Douglas KT
    Amino Acids; 2002 Jun; 22(4):297-308. PubMed ID: 12107758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of trypanothione reductase inhibitory activity by 1,3,4-thiadiazolium-2-aminide derivatives and molecular docking studies.
    Rodrigues RF; Castro-Pinto D; Echevarria A; dos Reis CM; Del Cistia CN; Sant'Anna CM; Teixeira F; Castro H; Canto-Cavalheiro M; Leon LL; Tomás A
    Bioorg Med Chem; 2012 Mar; 20(5):1760-6. PubMed ID: 22304847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: kinetic studies and structure-activity relationships.
    Bonse S; Santelli-Rouvier C; Barbe J; Krauth-Siegel RL
    J Med Chem; 1999 Dec; 42(26):5448-54. PubMed ID: 10639286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.
    Lee B; Bauer H; Melchers J; Ruppert T; Rattray L; Yardley V; Davioud-Charvet E; Krauth-Siegel RL
    J Med Chem; 2005 Nov; 48(23):7400-10. PubMed ID: 16279799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state.
    Lantwin CB; Schlichting I; Kabsch W; Pai EF; Krauth-Siegel RL
    Proteins; 1994 Feb; 18(2):161-73. PubMed ID: 8159665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex.
    Jacoby EM; Schlichting I; Lantwin CB; Kabsch W; Krauth-Siegel RL
    Proteins; 1996 Jan; 24(1):73-80. PubMed ID: 8628734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures.
    de Paula da Silva CH; Bernardes LS; da Silva VB; Zani CL; Carvalho I
    J Biomol Struct Dyn; 2012; 29(6):702-16. PubMed ID: 22546000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
    Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
    Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting effects of spermidine derivatives on Trypanosoma cruzi trypanothione reductase.
    O'Sullivan MC; Dalrymple DM; Zhou Q
    J Enzyme Inhib; 1996 Oct; 11(2):97-114. PubMed ID: 9204399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling of a competitive and an irreversible ligand generates mixed type inhibitors of Trypanosoma cruzi trypanothione reductase.
    Inhoff O; Richards JM; Brîet JW; Lowe G; Krauth-Siegel RL
    J Med Chem; 2002 Sep; 45(20):4524-30. PubMed ID: 12238931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 5,5'-dithiobis(2-nitrobenzamides) as alternative substrates for trypanothione reductase and thioredoxin reductase: a microtiter colorimetric assay for inhibitor screening.
    Davioud-Charvet E; Becker K; Landry V; Gromer S; Logé C; Sergheraert C
    Anal Biochem; 1999 Mar; 268(1):1-8. PubMed ID: 10036154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assaying phenothiazine derivatives as trypanothione reductase and glutathione reductase inhibitors by theoretical docking and molecular dynamics studies.
    Iribarne F; Paulino M; Aguilera S; Tapia O
    J Mol Graph Model; 2009 Nov; 28(4):371-81. PubMed ID: 19801198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
    Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase.
    Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds.
    Eberle C; Burkhard JA; Stump B; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2009 Dec; 4(12):2034-44. PubMed ID: 19847846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.